Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Cash from Financing Activities: 2018-2024

Historic Cash from Financing Activities for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to -$11.5 million.

  • Gossamer Bio's Cash from Financing Activities rose 566.19% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 119.12%. This contributed to the annual value of -$11.5 million for FY2024, which is 106.04% down from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Cash from Financing Activities is -$11.5 million, which was down 106.04% from $190.2 million recorded in FY2023.
  • Gossamer Bio's Cash from Financing Activities' 5-year high stood at $312.5 million during FY2020, with a 5-year trough of -$11.5 million in FY2024.
  • Its 3-year average for Cash from Financing Activities is $98.6 million, with a median of $117.1 million in 2022.
  • Per our database at Business Quant, Gossamer Bio's Cash from Financing Activities spiked by 3,417.27% in 2022 and then plummeted by 106.04% in 2024.
  • Yearly analysis of 5 years shows Gossamer Bio's Cash from Financing Activities stood at $312.5 million in 2020, then slumped by 98.93% to $3.3 million in 2021, then skyrocketed by 3,417.27% to $117.1 million in 2022, then skyrocketed by 62.40% to $190.2 million in 2023, then crashed by 106.04% to -$11.5 million in 2024.